Active Shortage Injection Hematology
Heparin Sodium Injection · #9 of 35 active shortages by FDA posting duration
Brand: HEPARIN SODIUM
FDA lists Heparin Sodium Injection as Active Shortage (Hospira, Inc., a Pfizer Company).
Availability on file: Available
Heparin Sodium Injection: Active Shortage
Available 10 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Heparin Sodium Injection
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Dosage Form
- Injection
- Presentation
- Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-7620-03)
- Package NDC
- 0409-7620-03
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Nov 14, 2017
- Last Updated
- Mar 13, 2026
- Therapeutic Category
- Hematology
Row fields from the FDA Drug Shortages database via openFDA.
Full Drug Profile
heparin
Side effects, interactions, warnings & more
Nearby, Other Heparin Shortage Records
Heparin Sodium Injection
Fresenius Kabi USA, LLC
Injection
Heparin Sodium Injection
Hospira, Inc., a Pfizer Company
Injection
Heparin Sodium Injection
Baxter Healthcare
Injection
Heparin Sodium Injection
Baxter Healthcare
Injection
Heparin Sodium Injection
Baxter Healthcare
Injection
Heparin Sodium Injection
B. Braun Medical Inc.
Injection